Skip to Sidebar Skip to Content

NANOncolytics

Nanoparticle encapsulation of oncolytic viruses for systemic cancer therapy.

  • Biotech & Life Sciences
  • Sheffield
Sector
Biotech & Life Sciences
Stage
Undisclosed
Based in
Sheffield
Funding raised
Undisclosed

NANOncolytics is a University of Sheffield-linked biotech developing nanoparticle technology that encapsulates oncolytic, cancer-killing viruses. Wrapping the virus in a nanoparticle is intended to let it be injected into the bloodstream rather than directly into a tumour, opening up treatment of tumours that are hard to reach. Cancer is its lead application, but the team says the encapsulation platform could also be applied in agritech, food, cosmeceuticals and pharmaceuticals. The company is at research and development stage and is seeking partners and investment.

Team

  • Faith Nutter Howard, CEO LinkedIn
  • Munitta Muthana, Chief Scientific Officer LinkedIn

← All UK startups · Is this your company? Request an update

More startups in the directory

Subscribe to Newsletter

Join me on this exciting journey as we explore the boundless world of web design together.